✦ LIBER ✦

Recombinant human thrombin: safety and immunogenicity in pediatric burn wound excision

✍ Scribed by Kevin N. Foster; R. Fred Mullins; David G. Greenhalgh; Richard L. Gamelli; Paul Glat; Christopher W. Lentz; Steven A. Kahn; Claus Brandigi; Paul Fredlund; W. Allan Alexander

Book ID: 116689191
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 285 KB
Volume: 46
Category: Article
ISSN: 0022-3468
DOI: 10.1016/j.jpedsurg.2011.05.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity and Safety of Re-Exposure

Immunogenicity and Safety of Re-Exposure to Recombinant Human Thrombin in Surgical Hemostasis

✍ Neil K. Singla; Antonios P. Gasparis; Jeffrey L. Ballard; Jeffrey M. Baron; Mich 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Safety and Immunogenicity Observations P

Safety and Immunogenicity Observations Pooled from Eight Clinical Trials of Recombinant Human Thrombin

✍ Jeffrey L. Ballard; Fred A. Weaver; Neil K. Singla; William C. Chapman; W. Allan 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 366 KB

Safety and Immunogenicity of Recombinant

Safety and Immunogenicity of Recombinant Human Thrombin: A Pooled Analysis of Results from 10 Clinical Trials

✍ Singla, Neil K.; Foster, Kevin N.; Alexander, W. Allan; Pribble, John P. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Effect of topical and subcutaneous epine

Effect of topical and subcutaneous epinephrine in combination with topical thrombin in blood loss during immediate near-total burn wound excision in pediatric burned patients

✍ J.P. Barret; P. Dziewulski; S.E. Wolf; M.H. Desai; R.J. Nichols II; D.N. Herndon 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 113 KB

5:3776. Safety, tolerability, and immuno

5:3776. Safety, tolerability, and immunogenicity of topical recombinant human thrombin in a Phase 1/2 study in subjects undergoing spine surgery

✍ Neil Singla; Sonia Singla; Jonathan Horne; Harry Lockstadt; Walter Krengel; Jeff 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 55 KB

A Phase 3b, Open-Label, Single-Group Imm

A Phase 3b, Open-Label, Single-Group Immunogenicity and Safety Study of Topical Recombinant Thrombin in Surgical Hemostasis

✍ Neil K. Singla; Jeffrey L. Ballard; Gregory Moneta; C. Duane Randleman Jr; Kenne 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 265 KB